WHO Resolution Intended to Address Global Counterfeit Drug Market
On January 21, the WHO 130th WHO Executive Board (EB) adopted a resolution for agenda item 6.13 “substandard/spurious/falsely-labelled/falsified/counterfeit medical products” [SFFC]. The resolution is intended
February 24, 2012
1 Comment